Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 397

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 397
---
 in the Proposed Charter and the Proposed Bylaws. This separate vote is not otherwise required by Cayman Islands law separate and apart from the Charter Approval Proposal and the Bylaws Approval Proposal, but, pursuant to SEC guidance, Denali is required to submit these provisions to its shareholders separately for approval, allowing shareholders the opportunity to present their separate views on important governance provisions. However, the shareholder votes regarding these proposals are advisory votes, and are not binding on Denali or the Denali Board (separate and apart from the approval of the Charter Approval Proposal and the Bylaws Approval Proposal). In the judgment of the Denali Board, these provisions are necessary to adequately address the needs of the post-BusinessCombination company. Furthermore, the Business Combination is not conditioned on the separate approval of the Advisory Governance Proposals (separate and apart from approval of the Charter Approval Proposal and the Bylaws Approval Proposal). Advisory Governance Proposals The following table sets forth a summary of the governance provisions applicable to the Advisory Governance Proposals. This summary is qualified by reference to the complete text of the Proposed Charter, a copy of which is attached to this proxy statement as Annex B. All shareholders are encouraged to read the Proposed Charter in its entirety for a more complete description of its terms.

| Advisory Governing Documents Proposal                     |     | Current Denali Charter                                                                                                                                                                                                         |     | Proposed Charter                                                                                                                                                                                                                       |
| Advisory Proposal A — Changes in Authorized Share Capital |     | The Current Denali Charter provides that the share capital of Denali is US$22,100 divided into 200,000,000 Denali Class A Ordinary Shares of a par value of US$0.0001 each, 20,000,000 Denali Class B Ordinary Shares of a par 
 value of US$0.0001 and 1,000,000 preference shares of a par value of US$0.0001 each.                                                                                                                                           |     | The Proposed Charter will authorize the issuance of up to 785,000,000 shares, par value $0.0001 per share, consisting of (i) 740,000,000 shares of common stock and (ii) 45,000,000 shares of preferred stock, of which not more than  
 6,000,000 shares will be designated as Series A Preferred Stock in connection with the Closing and pursuant to the New Semnur Certificate of Designations.                                                                             |
| Advisory Proposal B — Number of Directors                 |     | Pursuant to the